| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,056 | 25,527 | 32,244 | 26,525 | | Cost of Revenue | 8,076 | 7,885 | 8,622 | 26,803 | | | Gross Profit | 17,980 | 17,642 | 23,622 | (278) | | | Operating Expenses | | Research Development | 6,126 | 7,114 | 8,134 | 8,860 | | Selling General and Administrative | 11,266 | 11,506 | 13,304 | 15,323 | | Non Recurring | 46 | 520 | 1,296 | 57,284 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 542 | (1,498) | 888 | (81,745) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (494) | 161 | (406) | (42) | | Earnings Before Interest And Taxes | 48 | (1,337) | 482 | (81,787) | | Interest Expense | 7 | 10 | 30 | 13 | | Income Before Tax | 41 | (1,347) | 452 | (81,800) | | Income Tax Expense | 247 | 484 | 125 | 29,317 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (206) | (1,831) | 327 | (111,117) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (206) | (1,831) | 327 | (111,117) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($206) | ($1,831) | $327 | ($111,117) |
|
0.51% Nasdaq 
Income Statement
